The study titled “Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures” addresses the potential risks associated with transfusions of blood products from individuals who have received genetic vaccines. The authors highlight the various adverse effects reported after vaccination, including post-vaccination thrombosis and cardiovascular damage. They also discuss the wide range of diseases affecting different organ systems, including the nervous system.
The coronavirus pandemic led to the rapid implementation of genetic vaccination programs worldwide. However, the use of genetic vaccines, particularly those using modified mRNA encoding the spike protein and lipid nanoparticles, has raised concerns due to the observed adverse effects. The authors emphasize the need for medical professionals to be aware of these risks when considering blood transfusions using blood products derived from individuals who have been vaccinated or have suffered from long COVID.
To address these concerns, the authors propose specific measures, including tests, testing methods, and regulations. They suggest conducting thorough inspections and assessments to evaluate the potential harm and benefits of blood transfusions from genetic vaccine recipients. They also emphasize the importance of establishing diagnostic criteria for post-vaccination syndrome and its consequences.
